Clinical trial
Immune Response to High-Dose vs. Standard Dose Influenza Vaccine
NCT02297542 is registered in ClinicalTrials.gov with Health Sciences North Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immune Response to High-Dose vs. Standard Dose Influenza Vaccine
- Lead sponsor
- Health Sciences North Research Institute
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 1, 2014
- Completion date
- September 21, 2026
- Enrollment
- 393 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
elderly immune system